Amit Sachdev, EVP, Chief Patient Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 16,877 shares at $213.02 ($3.6M) on 2021-02-18, disclosed to the SEC on 2021-02-19.
Seasonal sale ($3.6M) by EVP, Chief Patient Officer — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $211.75 | 7,613 | $1.6M | 45.1% |
| 2 | $210.00 | 1,164 | $244K | 6.8% |
| 3 | $211.36 | 1,500 | $317K | 8.9% |
| 4 | $212.15 | 5,800 | $1.2M | 34.4% |
| 5 | $213.02 | 800 | $170K | 4.8% |
| Total | $211.79 avg | 16,877 |
| $3.6M |
| 100% |
| Filing → |
| VRTX | SELL | 2024-05-17 | $14K | — | Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |